Human neutralizing monoclonal antibodies to human immunodeficiency virus
US5652138A · kind A · utility
24Cited by
2References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 18, 1994 |
| Grant date | Jul 29, 1997 |
| Priority date | — |
| Expiry date | Jul 18, 2014 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention describes human monoclonal antibodies which immunoreact with and neutralize human immunodeficiency virus (HIV). Also disclosed are immunotherapeutic and diagnostic methods of using the monoclonal antibodies, as well as cell line for producing the monoclonal antibodies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.